| Company Name: |
OPULENT PHARMA
|
| Tel: |
+91-9106692785 +91-9106692785 |
| Email: |
info@opulentpharma.com |
| Products Intro: |
Product Name:Atenolol S-Isomer
CAS:93379-54-5
Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
|
- (S)-(-)-Atenolol
-
- $67.00 / 1mg
-
2024-11-20
- CAS:93379-54-5
- Min. Order:
- Purity: 100%
- Supply Ability: 10g
|
| | S(-)-ATENOLOL Basic information |
| Product Name: | S(-)-ATENOLOL | | Synonyms: | S-(-)-4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]BENZENEACETAMIDE;S(-)-ATENOLOL;S(-)-ATENOLOL >96% ACTIVE ENANTIOMER OF;Benzeneacetamide, 4-[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-;Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, (S)-;Esatenolol;s-(-)-4-(2-hydroxy-3-isopropylaminopropoxy)phenylacetamide;4-[(S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide | | CAS: | 93379-54-5 | | MF: | C14H22N2O3 | | MW: | 266.34 | | EINECS: | | | Product Categories: | Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Adrenoceptor | | Mol File: | 93379-54-5.mol |  |
| | S(-)-ATENOLOL Chemical Properties |
| Melting point | 148-152 °C(lit.) | | Boiling point | 508.0±50.0 °C(Predicted) | | density | 1.125±0.06 g/cm3(Predicted) | | storage temp. | Store at RT | | solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >6 mg/mL | | pka | 13.88±0.20(Predicted) | | form | solid | | color | pale pink | | optical activity | [α]25/D 16°, c = 1 in 1 M HCl | | Water Solubility | Soluble to 25 mM in water |
| WGK Germany | 3 | | RTECS | CY1488020 |
| | S(-)-ATENOLOL Usage And Synthesis |
| Uses | active enantiomer | | Uses | Antihypertensive;Adrenergic receptor antagonist | | Uses | Cardioselective β-adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic (class II). | | Definition | ChEBI: The (S)-enantiomer of atenolol. | | Biological Activity | The active enantiomer of atenolol ((RS)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide ), a cardioselective β -adrenergic blocker. |
| | S(-)-ATENOLOL Preparation Products And Raw materials |
|